HAWKARY PHARMACEUTICAL COMPANY# — Lisinopril Importer Profile
Pharmaceutical Importer · #8 buyer for Lisinopril · $537.4K import value · 13 shipments · TURKEY · DGFT Verified
HAWKARY PHARMACEUTICAL COMPANY# is the #8 importer of Lisinopril from India with $537.4K in import value and 13 verified shipments. HAWKARY PHARMACEUTICAL COMPANY# holds a 1.0% market share in Lisinopril imports based in TURKEY. The company sources from 1 verified supplier across 6 formulations shipped to 1 country. Overall, HAWKARY PHARMACEUTICAL COMPANY# imports 3 pharmaceutical products worth $1.6M across 3 therapeutic categories.
HAWKARY PHARMACEUTICAL COMPANY# — Lisinopril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Lisinopril to HAWKARY PHARMACEUTICAL COMPANY#?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $537.4K | 13 | 100.0% |
HAWKARY PHARMACEUTICAL COMPANY# sources Lisinopril from 1 verified Indian supplier based on 13 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does HAWKARY PHARMACEUTICAL COMPANY# Compare to Nearest Lisinopril Importers?
Buyers ranked immediately above and below #8 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | BROWN AND BURK UK LIMITED | UNITED KINGDOM | $852.4K | 19 | $44.9K |
| 4 | XXPINXXHARXXCEUXXCALXXINC | UNITED STATES | $850.0K | 17 | $50.0K |
| 8 | HAWKARY PHARMACEUTICAL COMPANY# ★ | TURKEY | $619.4K | 13 | $47.6K |
| 9 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $532.8K | 67 | $8.0K |
| 11 | APL SWIFT SERVICES MALTA LTD | MALTA | $501.7K | 52 | $9.6K |
HAWKARY PHARMACEUTICAL COMPANY# ranks #8 among 450 Lisinopril importers from India. Average shipment value of $47.6K compared to the market average of $15.6K. The closest competitors by value are BROWN AND BURK UK LIMITED and XXPINXXHARXXCEUXXCALXXINC.
Where Does HAWKARY PHARMACEUTICAL COMPANY# Import Lisinopril To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $537.4K | 13 | 100.0% |
HAWKARY PHARMACEUTICAL COMPANY# imports Lisinopril to 1 country. The primary destination is TURKEY receiving 100.0% of shipments worth $537.4K.
What Lisinopril Formulations Does HAWKARY PHARMACEUTICAL COMPANY# Import?
| Formulation | Value | Shipments |
|---|---|---|
| HIPRIL - A (AMLODIPINE 5MG & LISINOPRIL5MG TABLETS) (3X10S) - TAX INVOICE NO: 712202959 DT; 23.04.2024 | $135.6K | 3 |
| HIPRIL - A (AMLODIPINE 5MG + LISINOPRIL5MG TABLETS) (3X10S) - TAX INVOICE NO: 712203004 DT; 23.05.2024 | $132.5K | 3 |
| HIPRIL - A (AMLODIPINE LISINOPRIL TABLET | $100.0K | 2 |
| HIPRIL - A (AMLODIPINE & LISINOPRIL TABLETS) (3X10S) - TAX INVOICE NO: 712202849DT: 19.02.2024PCS | $69.2K | 3 |
| HIPRIL - A (AMLODIPINE 5MG + LISINOPRIL5MG TABLETS) (3X10S) - TAX INVOICE NO: 712203027 DT: 11.06.2024 | $50.0K | 1 |
| HIPRIL -A (AMLODIPINE 5MG + LISINOPRIL5MG TABLETS) (3X10s) - TAX INVOICE NO: 712203480 DT: 15.04.2025 | $50.0K | 1 |
HAWKARY PHARMACEUTICAL COMPANY# imports 6 distinct Lisinopril formulations from India. The top formulation is HIPRIL - A (AMLODIPINE 5MG & LISINOPRIL5MG TABLETS) (3X10S) with 3 shipments worth $135.6K.
Who Are the Top Buyers of Lisinopril from India and How Much Does HAWKARY PHARMACEUTICAL COMPANY# Import?
India exported $7.0M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. HAWKARY PHARMACEUTICAL COMPANY# imports $537.4K of this total, accounting for 1.0% of India's Lisinopril exports with 13 shipments from TURKEY. This is verified from 13 customs shipment records covering 6 distinct formulations.
What Is the Average Order Value for HAWKARY PHARMACEUTICAL COMPANY#'s Lisinopril Imports?
HAWKARY PHARMACEUTICAL COMPANY#'s average Lisinopril order value is $41.3K per consignment, based on 13 shipments totaling $537.4K. HAWKARY PHARMACEUTICAL COMPANY# is based in TURKEY and ranks #8 among all Lisinopril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Lisinopril to HAWKARY PHARMACEUTICAL COMPANY#?
HAWKARY PHARMACEUTICAL COMPANY# sources Lisinopril from 1 verified Indian supplier: MICRO LABS LIMITED ($537.4K, 100.0%). This is based on 13 customs records.
How Does HAWKARY PHARMACEUTICAL COMPANY# Compare to Other Lisinopril Importers?
HAWKARY PHARMACEUTICAL COMPANY# ranks #8 among 450 Lisinopril importers from India with a 1.0% market share. The top 3 importers are LUPIN PHARMACEUTICAL INC ($1.4M), BROWN AND BURK UK LIMITED ($852.4K), XXPINXXHARXXCEUXXCALXXINC ($850.0K). HAWKARY PHARMACEUTICAL COMPANY# processed 13 shipments from TURKEY.
About HAWKARY PHARMACEUTICAL COMPANY#
HAWKARY PHARMACEUTICAL COMPANY# imports 3 products worth $1.6M. Beyond Lisinopril, top products include Chlorpheniramine, Azithromycin. View the complete HAWKARY PHARMACEUTICAL COMPANY# profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: HAWKARY PHARMACEUTICAL COMPANY# matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as HAWKARY PHARMACEUTICAL COMPANY#'s capped import value divided by total capped export value for Lisinopril across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching HAWKARY PHARMACEUTICAL COMPANY# importing Lisinopril, covering 6 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Import Data for HAWKARY PHARMACEUTICAL COMPANY#
Access order-level details, pricing data, supplier connections, and competitive analysis for HAWKARY PHARMACEUTICAL COMPANY#'s Lisinopril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
HAWKARY PHARMACEUTICAL COMPANY#
Full Company Profile →
3 products · $1.6M total trade · 3 categories
HAWKARY PHARMACEUTICAL COMPANY# × Lisinopril
Verified from customs records
Company Overview
Top Products by HAWKARY PHARMACEUTICAL COMPANY#
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for HAWKARY PHARMACEUTICAL COMPANY#.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current order-level data, contact TransData Nexus.